Cargando…
Role of Emerging Insulin Technologies in the Initiation and Intensification of Insulin Therapy for Diabetes in Primary Care
In Brief This article explores some of the reasons for the delay in insulin initiation in primary care and evaluates new approaches to insulin therapy that may address these barriers and, therefore, improve insulin use by primary care providers.
Autores principales: | Brunton, Stephen A., Kruger, Davida F., Funnell, Martha M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Diabetes Association
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4714724/ https://www.ncbi.nlm.nih.gov/pubmed/26807007 http://dx.doi.org/10.2337/diaclin.34.1.34 |
Ejemplares similares
-
Safety and Efficacy of Insulin Degludec/Liraglutide (IDegLira) and Insulin Glargine U100/Lixisenatide (iGlarLixi), Two Novel Co-Formulations of a Basal Insulin and a Glucagon-Like Peptide-1 Receptor Agonist, in Patients With Diabetes Not Adequately Controlled on Oral Antidiabetic Medications
por: Wysham, Carol H., et al.
Publicado: (2018) -
Therapeutic Inertia and Delays in Insulin Intensification in Type 2 Diabetes: A Literature Review
por: Gavin, James R., et al.
Publicado: (2023) -
Improved Glycemic Control Following Transition to Tubeless Insulin Pump Therapy in Adults With Type 1 Diabetes
por: Mehta, Sanjeev N., et al.
Publicado: (2021) -
Patient Perceptions of Satisfaction and Quality of Life Regarding Use of a Novel Insulin Delivery Device
por: Isaacs, Diana, et al.
Publicado: (2023) -
Insulin initiation and intensification in patients with T2DM for the primary care physician
por: Unger, Jeff
Publicado: (2011)